Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Immunomedics Inc (IMMU) Com Stk USD0.01

Sell:$87.80 Buy:$87.81 Change: $0.08 (0.09%)
Market closed |  Prices as at close on 21 October 2020 | Switch to live prices |
Tender Offer

Immunomedics Inc Com Stk USD0.01

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 7 Oct 2020)

What is happening?

 

As you may be aware the Boards of Immunomedics Inc and Gilead Sciences Inc recently announced the terms of a Tender Offer. Under the terms of the Tender Offer holders of Immunomedics Inc Shares have been offered USD88.00 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD88.00 for each Immunomedics Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

How to make your choice

 

Please reply to this message with your instruction or call our Investment Helpdesk on 0117 900 9000 with your instruction after confirmation of your Security Information. If you wish to give an instruction online, please click on your «Product_description». Then, click on the Corporate Actions icon next to your Hydrogen Group plc holding and follow the instructions.

 

The Hargreaves Lansdown client deadline is noon on 16 October 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

 

×
Sell:$87.80
Buy:$87.81
Change: $0.08 (0.09%)
Market closed |  Prices as at close on 21 October 2020 | Switch to live prices |
Tender Offer

Immunomedics Inc Com Stk USD0.01

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 7 Oct 2020)

What is happening?

 

As you may be aware the Boards of Immunomedics Inc and Gilead Sciences Inc recently announced the terms of a Tender Offer. Under the terms of the Tender Offer holders of Immunomedics Inc Shares have been offered USD88.00 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD88.00 for each Immunomedics Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

How to make your choice

 

Please reply to this message with your instruction or call our Investment Helpdesk on 0117 900 9000 with your instruction after confirmation of your Security Information. If you wish to give an instruction online, please click on your «Product_description». Then, click on the Corporate Actions icon next to your Hydrogen Group plc holding and follow the instructions.

 

The Hargreaves Lansdown client deadline is noon on 16 October 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

 

×
Sell:$87.80
Buy:$87.81
Change: $0.08 (0.09%)
Market closed |  Prices as at close on 21 October 2020 | Switch to live prices |
Tender Offer

Immunomedics Inc Com Stk USD0.01

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 7 Oct 2020)

What is happening?

 

As you may be aware the Boards of Immunomedics Inc and Gilead Sciences Inc recently announced the terms of a Tender Offer. Under the terms of the Tender Offer holders of Immunomedics Inc Shares have been offered USD88.00 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD88.00 for each Immunomedics Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

How to make your choice

 

Please reply to this message with your instruction or call our Investment Helpdesk on 0117 900 9000 with your instruction after confirmation of your Security Information. If you wish to give an instruction online, please click on your «Product_description». Then, click on the Corporate Actions icon next to your Hydrogen Group plc holding and follow the instructions.

 

The Hargreaves Lansdown client deadline is noon on 16 October 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

 

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$87.75
Trade high:
$87.82
Year high:
$87.73
Market capitalisation
Market cap.
:
$20.25 bn
Previous close:
$87.72
Trade low:
$87.72
Year low:
$8.80
Shares in issue
Shares
:
231.16 m
Previous:
$0.11 (0.13%)
Previous:
$0.11
Volume:
n/a
Dividend yield:
n/a
Currency:
USD
Data delayed by at least 15 minutes.
* To buy US shares you must first complete and return a US government ‘W-8BEN’ form.

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look. Exchange disclaimer

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.